;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Alkermes, Zogenix neurology news

    Alkermes plc (NASDAQ:ALKS), Dublin, Ireland Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Zogenix filed suit challenging Massachusetts Gov. Deval Patrick's executive order banning the prescription or…

    Published on 4/14/2014
  • Alnylam chemistry news

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Chemistry Alnylam said the European Patent Office upheld European Patent No. EP 1423406 in oral opposition proceedings. The '406 patent is part of …

    Published on 4/14/2014
  • Astellas gene/cell therapy news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Gene/Cell therapy Astellas established a regenerative medicines unit to specialize in the discovery and R&D of regenerative medicines and cell therapies. …

    Published on 4/14/2014
  • Bayer, Natco cancer, generics news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Cancer, Generics On March 26, the Delhi High Court barred Natco from exporting a generic version of …

    Published on 4/14/2014
  • Biocon, Novartis endocrine/metabolic news

    Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Endocrine/Metabolic On March 27, Novartis filed a suit in the High Court of Delhi seeking an …

    Published on 4/14/2014
  • Biota Pharmaceuticals, Gilead, Chugai, GlaxoSmithKline, Roche infectious news

    Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Alpharetta, Ga. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London…

    Published on 4/14/2014
  • Capillary Film Technology diagnostic news

    Capillary Film Technology Ltd., West Sussex, U.K Business: Diagnostic Capillary Film Technology received a 98,000 ($162,366) Small Business Innovation Research (SBIR) from NHS England to develop a point-of-care …

    Published on 4/14/2014
  • Compugen cancer news

    Compugen Ltd. (NASDAQ:CGEN; Tel Aviv:CGEN), Tel Aviv, Israel Business: Cancer In response to Israeli news reports that the husband of Compugen CFO Dikla Axselbrad is being investigated for alleged insider trading, …

    Published on 4/14/2014
  • Eli Lilly, Takeda endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic A jury in the U.S. District Court for the Western District of Louisiana, ordered …

    Published on 4/14/2014
  • Eli Lilly, Unitio endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Unitio, Boston, Mass. Business: Endocrine/Metabolic Eli Lilly partnered with the non-profit's T1D Exchange to use real-world, patient-centric data to identify ways to …

    Published on 4/14/2014
  • Fred Hutchinson Cancer Research cancer news

    Fred Hutchinson Cancer Research, Seattle, Wash. Business: Cancer Fred Hutchinson Cancer Research said the Bezos family donated $20 million to the center to develop genetically modified human T cells to treat cancer. The…

    Published on 4/14/2014
  • Fresenius, Teva, Eli Lilly cancer news

    Fresenius SE & Co. KGaA (Xetra:FRE: OTCQX:FSNUY), Bad Homburg, Germany Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer The U.S. …

    Published on 4/14/2014
  • Genentech, Hospira, Roche cancer, biosimilars news

    Genentech Inc., South San Francisco, Calif. Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Roche (SIX:ROG; OCTQX:RHHBY), Basel, Switzerland Business: Cancer, Biosimilars The Chancery Division of England's High Court of …

    Published on 4/14/2014
  • Gilead, Express Scripts, WHO pharmaceuticals news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. World Health Organization, Geneva, Switzerland Business: Pharmaceuticals Express Scripts said it will ask…

    Published on 4/14/2014
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline said it is investigating allegations of improper conduct in its Iraq business. The pharma said it employs less than 60 …

    Published on 4/14/2014
  • H. Lee Moffitt Cancer Center, Deloitte LLP cancer news

    H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla. Deloitte LLP, New York, N.Y. Business: Cancer Moffitt's M2Gen subsidiary joined a real-world evidence and analytics consortium led by Intermountain …

    Published on 4/14/2014
  • IOTA Pharmaceuticals Ltd., Top Institute Pharma, European Screening Port, Fundacao Oswaldo Cruz, Spanish National Research Council, Theodore Bilharz Research Institute, University of Antwerp, ...

    IOTA Pharmaceuticals Ltd., Cambridge, U.K. Top Institute Pharma, Leiden, The Netherlands European Screening Port, Hamburg, Germany Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil Spanish National Research Council, Madrid,…

    Published on 4/14/2014
  • NIH other news

    National Institutes of Health, Bethesda, Md. Business: Other NIH's Defense Advanced Research Projects Agency (DARPA) launched the Biological Technologies Office (BTO) to fund research into biological systems and …

    Published on 4/14/2014
  • Novartis cancer, cardiovascular news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cancer, Cardiovascular Novartis appointed new senior executives in Japan after a preliminary review of a report by an independent panel uncovered possible …

    Published on 4/14/2014
  • Novartis, Malaria No More infectious news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Malaria No More, New York, N.Y. Business: Infectious The partners are providing 2 million treatments of a pediatric formulation of Novartis' malaria drug Coartem …

    Published on 4/14/2014
  • Takeda cardiovascular news

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cardiovascular Takeda said the Japan Pharmaceutical Manufacturers Association (JPMA) imposed sanctions on the company for promotional activities …

    Published on 4/14/2014
  • Teva, Mylan autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Autoimmune Mylan said the U.S. Patent and Trademark Office issued a final rejection of Teva's …

    Published on 4/14/2014
  • University of California neurology news

    University of California, San Francisco, Calif. Business: Neurology The university launched the online Brain Health Registry to create a pool of research subjects for studies on neurological diseases, such as Alzheimer'…

    Published on 4/14/2014
  • AbbVie autoimmune news

    AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Autoimmune AbbVie dropped lawsuits against EMA challenging the agency's decision to grant access to raw patient-level data for autoimmune drug Humira adalimumab. AbbVie …

    Published on 4/7/2014
  • Bayer pharmaceuticals news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Business: Pharmaceuticals Bayer's Bayer HealthCare AG subsidiary will invest about 100 million ($1.4 billion) to increase production capacity of its plant in Beijing. Bayer …

    Published on 4/7/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993